Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00605956 · ClinicalTrials.gov registry record · Phase 1
NatrOVA Photoallergy Study - NatrOVA Creme Rinse in Healthy Volunteers
A Phase 1 study, sponsored by ParaPRO.
- Completed
- Registry status
- Phase 1
- Development phase
- 65
- Enrollment target
NCT00605956: Completed Phase 1 study, sponsored by ParaPRO.
NCT00605956 is a Phase 1 study that has completed, run by ParaPRO. The registered enrollment target is 65 participants, roughly in line with the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00605956, a Phase 1 study, has completed, sponsored by ParaPRO.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 65 participants
- Enrollment target
Study Summary
Photoallergic reactions are assumed to be due to a delayed cell-mediated hypersensitivity response that requires the presence of ultraviolet irradiation. The predictive procedure is, therefore, based on modification of the Repeated Insult Patch Test (Kaidbey, 1991). Duplicate sets of patches of test articles are used with exposure of only one set to UV radiation and subsequent evaluation of both sets for skin reactions in order to compare irradiated versus non-irradiated test sites.
Interventions
- DRUG NatrOVA Creme Rinse - 1%
- DRUG NatrOVA Creme Rinse Vehicle Only
- DRUG Blank Patch
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 65 participants |
| Start Date | 2008-01 |
| Est. Completion | 2008-02 |
| Phase | Phase 1 |
What the finished NCT00605956 record still lists
NCT00605956 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 65 participants, a relatively small participant target, roughly in line with the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target.
The record links to 0 conditions, and to 3 interventions - of which NatrOVA Creme Rinse - 1% is the first listed.
NCT00605956 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00605956 about?
NCT00605956 is a clinical study titled "NatrOVA Photoallergy Study - NatrOVA Creme Rinse in Healthy Volunteers". Photoallergic reactions are assumed to be due to a delayed cell-mediated hypersensitivity response that requires the presence of ultraviolet irradiation. The predictive procedure is, therefore, based on modification of the Repeated Insult Patch Test (Kaidbey, 1991). Duplicate sets of patches of test...
What is the current status of trial NCT00605956?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 65 participants. The study started on 2008-01. Estimated completion is 2008-02.
What interventions are being tested in trial NCT00605956?
The interventions under investigation include: NatrOVA Creme Rinse - 1% (DRUG), NatrOVA Creme Rinse Vehicle Only (DRUG), Blank Patch (DRUG).
Who is sponsoring clinical trial NCT00605956?
This trial is sponsored by ParaPRO, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00605956's enrollment target sits among peer trials
65 798th of 2000 higher than 1,193 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03366116 · 65 participants · Phase 1
5-aza-4'-Thio-2'-Deoxycytidine (Aza-TdC) in People With Advanced Solid Tumors
- NCT03603730 · 65 participants · NA
Vagal Nerve Stimulation for Functional Dyspepsia and Gastroparesis
- NCT03796559 · 65 participants · NA
Magseed Enabled Long-Term Localization of Axillary Lymph Nodes
- NCT03993106 · 65 participants · Phase 2
A Study of sEphB4-HSA in Kaposi Sarcoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia